SONOMA PHARMACEUTICALS, INC. Contract Liability (Deferred Revenue)
SONOMA PHARMACEUTICALS, INC. (SNOA) had Contract Liability (Deferred Revenue) of $150.00 thousand as of 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-02-16
- 2020-12-31: Contract with Customer, Liability, Current $150.00K.
- 2020-09-30: Contract with Customer, Liability, Current $150.00K.
- 2020-03-31: Contract with Customer, Liability, Current $228.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-12-31 | $150.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $150.00K 10-Q · filed 2020-11-20 |
| 2020-03-31 | $228.00K 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |